AbbVie (ABBV)

$116.30 2.57 (2.16%)

19:00 EDT ABBV Stock Quote Delayed 30 Minutes

The 10 Best Dividend Income Growers in the S&P 500

By Will Ashworth, InvestorPlace Contributor Jul 22, 2021

If you're looking for dividend stocks to own from the S&P 500, these 10 Dividend Aristocrats are doing a lot better than most.

3 High-Yield Dividend Aristocrats To Buy Now

7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield

7 Super-Safe Dividend Stock Performers to Buy

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 9.02M

Day's Range 116.12 - 119.06

52-Week Range 79.11 - 119.13

Dividend & Yield 5.20 (4.47%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

3 High-Yield Stocks With Secure Payouts

By Bob Ciura, Sure Dividend Jun 25, 2021

The advantages these companies bring to the table makes their payouts reliable. That makes them excellent dividend stocks to buy.

7 Overlooked Blue-Chip Stocks to Buy for Eagle-Eyed Investors

By Josh Enomoto, InvestorPlace Contributor Jun 23, 2021

While the excitement in the market remains centered on meme trades, these overlooked blue-chip stocks offer much-needed stability.

7 Best Long-Term Dividend Stocks for Your Retirement Portfolio

By Tezcan Gecgil, InvestorPlace Contributor May 19, 2021

Given the low interest rate environment, investors look for dividend shares. Here are seven long-term stocks for retirement portfolios.

7 Warren Buffett Stocks to Buy for the Next Decade

By Josh Enomoto, InvestorPlace Contributor May 7, 2021

As one of the world's greatest investors, Warren Buffett knows a thing or two about acquiring the best stocks to buy.

7 Value Stocks You Want In Your Life

By Josh Enomoto, InvestorPlace Contributor Apr 30, 2021

Although growth-related investments have been all the rage, smart investors should see the potential in buying value stocks.

7 Pharmaceutical Stocks To Buy For Valuation Plus Solid Dividends

By Bret Kenwell, InvestorPlace Contributor Apr 29, 2021

High-quality pharmaceutical stocks come with steady business, low valuations and solid dividend. Let's look at a handful of them now.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Cannabis Stocks That Offer Much More Than Just Pot

By Josh Enomoto, InvestorPlace Contributor Mar 30, 2021

You may be surprised that not all cannabis stocks are focused entirely on weed. Here are some diversified companies to consider.

7 Value Stocks That Will Reward Investors Who Have Some Patience

By Alex Sirois Mar 26, 2021

Value stocks aren't always a sure thing despite their reassuring metrics. These seven seem to be close to it though.

4 Top Stock Trades for Thursday: ABBV, TLT, PDD, FIVE

By Bret Kenwell, InvestorPlace Contributor Mar 17, 2021

AbbVie, the iShares 20+ Treasury Bond ETF, Pinduoduo and Five Below were our top stock trades for Thursday. Now, let's look at the charts.

7 Blue-Chip Stocks With Strong Dividend Yields

By Joel Baglole Mar 16, 2021

Blue-chip stocks appeal to investors with their stability, consistent returns and dividend yield. In this article, we look at seven blue-chip stocks with strong dividends that could offer big returns.

7 Great Dividend Stocks Outside the Energy Sector

By Alex Sirois Mar 3, 2021

Dividend stocks come in many flavors although investors may associate them primarily with the energy sector. These seven stocks cross industries.

7 Safe Stocks You Can Hold Onto Forever

By Chris Lau, InvestorPlace Contributor Mar 1, 2021

Euphoric markets are widening the gap between value and growth investments. Let's take a look at safe stocks to buy and hold forever.

9 Safe Stocks for Your 401k

By Josh Enomoto, InvestorPlace Contributor Feb 16, 2021

While everybody is chasing the moon and the stars, it might be prudent for you to consider these safe stocks for your 401K.

4 Top Stock Trades for Thursday: AMZN, SPOT, BMY, ABBV

By Bret Kenwell, InvestorPlace Contributor Feb 3, 2021

Amazon, Spotify, Bristol-Myers Squibb and AbbVie were our top stock trades for Thursday. Let's look at the charts of these earnings movers.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor Feb 2, 2021

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

7 Dividend Aristocrats That Will Outlive Us All

By Tezcan Gecgil, InvestorPlace Contributor Jan 22, 2021

These seven Dividend Aristocrats are among the royalty of passive-income generator companies

7 Pharmaceutical Stocks With Exciting Plans for 2021

By Bret Kenwell, InvestorPlace Contributor Jan 13, 2021

Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.

7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields

By Louis Navellier and the InvestorPlace Research Staff Jan 11, 2021

These hot stocks combine healthy dividends with lasting brand names, making them some of the smartest picks on the market.

The Top 7 Pharmaceutical Stocks for the Next 10 Years

By Alex Sirois Jan 11, 2021

Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.

AMZN PRICE PREDICTIONS

AbbVie (ABBV)

The 10 Best Dividend Income Growers in the S&P 500

3 High-Yield Dividend Aristocrats To Buy Now

7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield

7 Super-Safe Dividend Stock Performers to Buy

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMZN PRICE PREDICTIONS

AbbVie (ABBV)

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ABBV Stock Predictions, Articles, and AbbVie News

Subscriber Sign in